Need a specific person's email?
Browse InSphero's employee directory (about 82 employees) and reveal verified emails free.
InSphero's most common email format is First.Last@insphero.com (ex. John.Doe@insphero.com), used for 95% of insphero.com addresses. InSphero uses 4 email patterns.
| Format | Example | Share of insphero.com |
|---|---|---|
| First.Last@insphero.comMost common | John.Doe@insphero.com | |
| First.Middle@insphero.com | John.Michael@insphero.com | |
| FirstMiddle.Last@insphero.com | JohnMichael.Doe@insphero.com | |
| FirstLast@insphero.com | JohnDoe@insphero.com |
Browse InSphero's employee directory (about 82 employees) and reveal verified emails free.
Biotechnology ResearchZurich, Switzerland51-200 Employees
InSphero is a biotechnology research company based at 27a Wagistrasse, Schlieren, Zurich 8952, Switzerland, with 51-200 employees. The company develops 3D in vitro spheroid-based models and related platforms to support drug safety and efficacy testing. Its product areas cover liver safety, liver disease, islet biology, and oncology and immunology. InSphero has pursued growth through acquisitions and partnerships, including the 2026 acquisition of PhenoVista Biosciences and the 2025 acquisitions of Doppl SA and Sunbioscience, as well as a 2026 partnership with PharmaNest. In 2026, InSphero launched the 3D InSight Drug-Induced Gastrointestinal Toxicity platform, reflecting ongoing platform evolution.
Most common format
First.Last@insphero.com
Example: John.Doe@insphero.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.